
If you have any other questions, please contact our experts.
Microparticles composed of highly porous poly(lactic acid) (PLA) modified with amphiphilic poly(ethylene glycol)–cholesterol (PEG–Chol) were prepared as platforms for drug delivery. PLA and poly(lactide-co-glycolide) (PLGA) nanoparticles suffer from low drug loading capacity and burst release effect. However, this hybrid carrier exhibited a high drug loading efficiency and a sustained drug release profile.
The PEG–Chol modification confers dual functionality:
(i) enhanced aqueous dispersibility for prolonged circulation, and
(ii) membrane-anchoring capabilities that promote cellular interaction and endocytosis.
Employing lipophilic drugs with poor solubility and systemic toxicity profiles, such as curcumin (Cur) and tamoxifen (Tmx), the system successfully displayed promising anticancer activity. Testing on MCF-7 breast cancer cells revealed successful intracellular uptake and significant cytotoxicity reduction of cell viability. These results highlight the potential for this system to serve as a flexible and high-performance delivery platform for effective breast cancer treatment.
Fig. 2 (a) A detailed description of the methodology used to obtain porous PLA microparticles (MPs) loaded with the drug, and (b) a three-step protocol for their surface functionalization. (Chettupalli A K, et al. 2025)
References
Cat NO.: PIE-0018
CAS NO.: 4537-78-4
Cat NO.: PIE-0019
CAS NO.: 4235-95-4
Cat NO.: PIE-0016
CAS NO.: 4537-77-3
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
